Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Spectroscopy IDs Potential Metabolic Markers to Diagnose Fibromyalgia
...
Already a member? Log in here
Federal Effort to Control HIV Depends on Increasing Testing, Treatment Adherence
From - Diagnostic Testing & Emerging Technologies
To control the spread of HIV in the United States, HIV infection must be diagnosed early and persons with HIV infection must be…
Serial CRP Results Predict Continued Risk Following Heart Attack
From - Diagnostic Testing & Emerging Technologies
Serial measurement of high-sensitivity C-reactive protein (hsCRP) levels following acute coronary syndrome may help…
New Point-of Care Paper Test May Improve Diagnosis of Preeclampsia
From - Diagnostic Testing & Emerging Technologies
The Congo Red Dot (CRD) Paper Test is a simple, rapid, non-invasive tool that that may improve triage and the accuracy of preeclampsia (PE) diagnosis at the point of care, according to…
Microbiology Testing Rates Low For Hospital-Acquired Infections
From - Diagnostic Testing & Emerging Technologies
The European Centre for Disease Control and Prevention (ECDC) estimates that there are 9 million cases of health care-associated infections…
Comprehensive, School-based Cardiovascular Screening Is Feasible, Effective
...
Already a member? Log in here
Progress Seen With EGFR Testing, But Adoption Still Lagging
From - Diagnostic Testing & Emerging Technologies
Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in…
Can a Blood Test Quantify Pain?
From - Diagnostic Testing & Emerging Technologies
A new test could help clinicians objectively measure pain. According to a study published…
Compliance Alert: FDA Warning Letter to Inova Genomics Laboratory